Offer - Urjas Oil for just ₹ 1 X
Carbokem Novo is a prescription drug, available for use as Injection. It is typically used for the treatment of Ovarian Cancer. Carbokem Novo also has some secondary and off-label uses. These are listed below.
The optimal dosage of Carbokem Novo is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Carbokem Novo can also lead to other problems, which have been listed below. Such side effects of Carbokem Novo normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Carbokem Novo's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Carbokem Novo has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Carbokem Novo related warnings section.
Carbokem Novo is contraindicated in people with pre-existing medical conditions like Anemia, Neutropenia, Infections as it can result in adverse effects. The section on Carbokem Novo contraindications lists all such conditions.
Drug interactions for Carbokem Novo have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Carbokem Novo is not safe while driving, and is is not addictive in nature.
Carbokem Novo is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Is the use of Carbokem Novo safe for pregnant women?
Pregnant women may get severe side effects after taking Carbokem Novo. If you are pregnant, do not take Carbokem Novo without a doctor's advice.
Is the use of Carbokem Novo safe during breastfeeding?
Taking Carbokem Novo may lead to serious side effects if you are breastfeeding. Carbokem Novo should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Carbokem Novo on the Kidneys?
There may be some adverse effects on kidney after taking Carbokem Novo. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Carbokem Novo on the Liver?
Carbokem Novo is completely safe for the liver.
What is the effect of Carbokem Novo on the Heart?
Carbokem Novo is not harmful for the heart.
Carbokem Novo should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Carbokem Novo unless your doctor advises you to do so -
Is this Carbokem Novo habit forming or addictive?
Carbokem Novo does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Carbokem Novo can make you feel drowsy.
Is it safe?
Carbokem Novo is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Carbokem Novo cannot treat any kind of mental disorder.
Interaction between Food and Carbokem Novo
Taking Carbokem Novo with food does not cause any problems.
Interaction between Alcohol and Carbokem Novo
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Carbokem Novo.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 282-283
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Paraplatin® (carboplatin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Carboplatin Accord(carboplatin)